Xin Yan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 11
- Cancer, Hypoxia, and Metabolism 7
-
- Cancer-related gene regulation 11
- PI3K/AKT/mTOR signaling in cancer 10
- RNA modifications and cancer 7
- Co-authors
- Yuping XiaoJing ZhaoDan SunHongju WuGang WangHua ShenYongsheng WangHua‐chuan Zheng
- Journals
- Journal of Clinical Oncology (8 papers)World Journal of Gastroenterology (5 papers)Journal of Thoracic Oncology (3 papers)OncoTargets and Therapy (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xin Yan
145 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 522
- Oncology 567
- Molecular Biology 1.2k
- Cell Biology 178
- Immunology 227
Countries citing papers authored by Xin Yan
This map shows the geographic impact of Xin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Yan more than expected).
Fields of papers citing papers by Xin Yan
This network shows the impact of papers produced by Xin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Yan. The network helps show where Xin Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 2 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 5 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 9 | |
| 12 | Knockdown of ROS proto-oncogene 1 inhibits migration and invasion in gastric cancer cells by targeting the PI3K/Akt signaling pathway | 2019 | 0 |
| 13 | 2018 | 1 | |
| 14 | 2015 | 9 | |
| 15 | 2011 | 37 | |
| 16 | 2009 | 10 | |
| 17 | Study of Wenyang Huoxue Fang in treating patients with acute coronary syndrome. | 2009 | 1 |
| 18 | Low-dose suramin enhances antitumor activity of mitomycin C in bladder tumors | 2004 | 3 |
| 19 | EFFECTS OF MUTATION AND EXPRESSION OF PTEN GENE mRNA ON TUMORIGENESIS AND PROGRESSION OF EPITHELIAL OVARIAN CANCER | 2004 | 1 |
| 20 | 2003 | 2 |
About Xin Yan
Xin Yan is a scholar working on Cancer Research, Molecular Biology, Oncology, Applied Microbiology and Biotechnology and Pathology and Forensic Medicine, having authored 161 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related gene regulation (11 papers), Cancer-related molecular mechanisms research (11 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), RNA modifications and cancer (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Gastric Cancer Management and Outcomes (7 papers), Biofield Effects and Biophysics (7 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Cancer Research (522 citations), Oncology (567 citations), Molecular Biology (1.2k citations), Cell Biology (178 citations) and Immunology (227 citations). Xin Yan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuping Xiao, Jing Zhao, Dan Sun, Dan Sun, Hongju Wu, Gang Wang, Hua Shen, Yongsheng Wang, Hua‐chuan Zheng and Nan Wang. Their work appears in journals such as Journal of Clinical Oncology, World Journal of Gastroenterology, Journal of Thoracic Oncology, OncoTargets and Therapy and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.